Oxidation of aromatic N-heterocyclic compounds to N-oxides by Verticillium sp. GF39 cells

Journal of Bioscience and Bioengineering

Volumn 115, Issue 6, 2013, Pages 651-653

  Mitsukura, Koichi ^a   Hayashi, Masafumi ^a   Yoshida, Toyokazu ^a   Nagasawa, Toru ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Aromatic N heterocycles; N Oxide; Oxidation; Pyridine ring; Verticillium; Whole cell catalyst

Indexed keywords

N-HETEROCYCLES; N-OXIDE; PYRIDINE RINGS; VERTICILLIUM; WHOLE-CELL CATALYSTS;

AROMATIC COMPOUNDS; CELLS; OXIDATION; PYRIDINE;

CYTOLOGY;

AROMATIC COMPOUND; HETEROCYCLIC COMPOUND; ISOQUINOLINE DERIVATIVE; OXIDE; PYRIDINE DERIVATIVE; QUINOLINE DERIVATIVE;

ARTICLE; CHEMICAL REACTION; FUNGAL CELL; INCUBATION TIME; NONHUMAN; OXIDATION; VERTICILLIUM; WHOLE CELL;

CYCLIC N-OXIDES; ISOQUINOLINES; OXIDATION-REDUCTION; PICOLINES; PYRIDINES; VERTICILLIUM;

VERTICILLIUM SP.;

EID: 84876972449     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2012.12.002     Document Type: Article

References (17)

1. Nagasawa T., Mathew C.D., Mauger J., Yamada H. Nitrile hydratase-catalyzed production of nicotinamide from 3-cyanopyridine in Rhodococcus rhodochrous J1. Appl. Environ. Microbiol. 1988, 54:1766-1769.
2. Mathew C.D., Nagasawa T., Kobayashi M., Yamada H. Nitrilase-catalyzed production of nicotinic acid from 3-cyanopyridine in Rhodococcus rhodochrous J1. Appl. Environ. Microbiol. 1988, 54:1030-1032.
3. Wieser M., Yoshida T., Nagasawa T. Microbial synthesis of pyrrole-2-carboxylate by Bacillus megaterium PYR2910. Tetrahedron Lett. 1998, 39:4309-4310.
4. Yoshida T., Fujita K., Nagasawa T. Novel reversible indole-3-carboxylate decarboxylase catalyzing nonoxidative decarboxylation. Biosci. Biotechnol. Biochem. 2002, 66:2388-2394.
5. Yasuda M., Sakamoto T., Sashida R., Ueda M., Morimoto Y., Nagasawa T. Microbial hydroxylation of 3-cyanopyridine to 6-hydroxy-3-cyanopyridine. Biosci. Biotechnol. Biochem. 1998, 59:572-575.
6. Nagasawa T., Hurh B., Yamane T. Production of 6-hydroxynicotinic acid from nicotinic acid by resting cells of Pseudomonas fluorescens TN5. Biosci. Biotechnol. Biochem. 1998, 58:665-668.
7. Uchida A., Ogawa M., Yoshida T., Nagasawa T. Quinolinate dehydrogenase and 6-hydroxyquinolinate decarboxylase involved in the conversion of quinolic acid to 6-hydroxypicolinic acid by Alcaligenes sp. strain UK21. Appl. Microbiol. Biotechnol. 2003, 180:81-87.
8. Uchida A., Ogawa M., Yoshida T., Nagasawa T. Regioselective hydroxylation of quinolinic acid, lutidinic acid and isocinchomeronic acid by resting cells of pyridine dicarboxylic acid-degrading microorganisms. Appl. Microbiol. Biotechnol. 2003, 62:337-341.
9. Yoshida T., Sada Y., Nagasawa T. Bioconversion of 2,6-dimethylpyridine to 6-methylpicolinic acid by Exophiala dermatitidis (Kano) de Hoog DA5501. Appl. Microbiol. Biotechnol. 2010, 86:1165-1170.
10. Tagat J.R., Steensma R.W., McCombie S.W., Nazareno D.V., Lin S.-I., Neustadt B.R., Cox K., Xu S., Wojcik L., Murray M.G. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist. J. Med. Chem. 2001, 44:3343-3346. other 3 authors.
11. Strizki J.M., Xu S., Wagner N.E., Wojcik L., Liu J., Hou Y., Endres M., Palani A., Shapiro S., Clader J.W. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 22:12718-12723. other 15 authors.
12. Seto M., Aramaki Y., Imoto H., Aikawa K., Oda T., Kanzaki N., Iizawa Y., Baba M., Shiraishi M. Orally active CCR5 antagonists as anti-HIV agents 2: synthesis and biologival activities of anilide derivatives containing a pyridine N-oxide. Chem. Pharm. Bull. 2004, 52:818-829.
13. Monge A., Palop J.A., de Ceráin A.L., Senador V., Martínez-Crespo F.J., Sainz Y., Narro S., García E., de Miguel C., González M. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. J. Med. Chem. 1995, 38:1786-1792. other 4 authors.
14. Nagasawa H., Yamashita M., Mikamo N., Shimamura M., Oka S., Uto Y., Hori H. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2002, 132:33-40.
15. Krueger S., Williams D.E. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmcol. Ther. 2005, 106:357-387.
16. Colby J., Stirling D.I., Dalton H. The soluble methane mono-oxygenase of Methlococcus capsulatus. Biochem. J. 1977, 165:392-405.
17. Ullrich R., Dolge C., Kluge M., Hofrichter M. Pyridine as novel substrate for regioselective oxygenation with aromatic peroxygenase from Agrocybe aegeritia. FEBS Lett. 2008, 582:4100-4106.